| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospitals, Veterans | 63 | 2021 | 160 | 11.980 |
Why?
|
| Quality Indicators, Health Care | 62 | 2021 | 337 | 11.140 |
Why?
|
| United States Department of Veterans Affairs | 80 | 2024 | 544 | 10.240 |
Why?
|
| Patient Safety | 31 | 2024 | 243 | 8.970 |
Why?
|
| Safety Management | 32 | 2024 | 137 | 6.440 |
Why?
|
| Veterans | 43 | 2024 | 765 | 6.190 |
Why?
|
| Postoperative Complications | 41 | 2022 | 1302 | 5.580 |
Why?
|
| Patient Readmission | 25 | 2022 | 430 | 5.020 |
Why?
|
| United States | 175 | 2024 | 7827 | 4.380 |
Why?
|
| Quality Improvement | 21 | 2024 | 441 | 4.140 |
Why?
|
| Ambulatory Surgical Procedures | 15 | 2021 | 49 | 3.900 |
Why?
|
| Quality Assurance, Health Care | 16 | 2017 | 255 | 3.560 |
Why?
|
| Quality of Health Care | 30 | 2022 | 519 | 3.530 |
Why?
|
| Health Services Research | 30 | 2021 | 271 | 3.140 |
Why?
|
| Veterans Health | 13 | 2023 | 158 | 3.060 |
Why?
|
| Medical Errors | 24 | 2018 | 196 | 2.940 |
Why?
|
| Surgical Procedures, Operative | 19 | 2024 | 141 | 2.800 |
Why?
|
| Risk Adjustment | 28 | 2017 | 94 | 2.680 |
Why?
|
| Ambulatory Care | 13 | 2024 | 311 | 2.650 |
Why?
|
| Community Health Services | 7 | 2021 | 128 | 2.330 |
Why?
|
| Medicare | 27 | 2022 | 612 | 2.310 |
Why?
|
| United States Agency for Healthcare Research and Quality | 16 | 2018 | 30 | 2.300 |
Why?
|
| Humans | 255 | 2025 | 63309 | 2.230 |
Why?
|
| Aged | 126 | 2025 | 14396 | 2.130 |
Why?
|
| Retrospective Studies | 75 | 2024 | 6638 | 2.090 |
Why?
|
| Middle Aged | 121 | 2025 | 17558 | 1.920 |
Why?
|
| Hospital Administration | 12 | 2016 | 43 | 1.890 |
Why?
|
| Male | 152 | 2025 | 29834 | 1.880 |
Why?
|
| Female | 158 | 2025 | 32806 | 1.830 |
Why?
|
| Primary Health Care | 11 | 2024 | 690 | 1.830 |
Why?
|
| Algorithms | 14 | 2020 | 999 | 1.790 |
Why?
|
| Health Services Accessibility | 12 | 2024 | 564 | 1.770 |
Why?
|
| Diagnosis-Related Groups | 17 | 2022 | 87 | 1.680 |
Why?
|
| Hospitals | 9 | 2022 | 392 | 1.530 |
Why?
|
| Benchmarking | 12 | 2021 | 137 | 1.520 |
Why?
|
| Arthroplasty, Replacement, Knee | 4 | 2022 | 126 | 1.490 |
Why?
|
| Patient Discharge | 12 | 2019 | 511 | 1.490 |
Why?
|
| Inpatients | 13 | 2019 | 303 | 1.300 |
Why?
|
| Clinical Coding | 9 | 2013 | 44 | 1.290 |
Why?
|
| Leadership | 6 | 2020 | 206 | 1.250 |
Why?
|
| Mental Disorders | 11 | 2017 | 792 | 1.220 |
Why?
|
| Surgical Wound Dehiscence | 3 | 2013 | 16 | 1.150 |
Why?
|
| Rural Population | 5 | 2024 | 203 | 1.140 |
Why?
|
| Cross-Sectional Studies | 23 | 2024 | 2569 | 1.130 |
Why?
|
| Predictive Value of Tests | 21 | 2016 | 1082 | 1.070 |
Why?
|
| Hospital Mortality | 19 | 2022 | 874 | 1.020 |
Why?
|
| Risk Factors | 37 | 2020 | 5345 | 1.020 |
Why?
|
| Databases, Factual | 19 | 2020 | 868 | 1.020 |
Why?
|
| International Classification of Diseases | 4 | 2019 | 136 | 1.010 |
Why?
|
| Pulmonary Embolism | 5 | 2018 | 172 | 1.010 |
Why?
|
| Respiratory Insufficiency | 3 | 2014 | 155 | 1.000 |
Why?
|
| Program Development | 3 | 2018 | 207 | 0.990 |
Why?
|
| Reproducibility of Results | 23 | 2018 | 1650 | 0.980 |
Why?
|
| Length of Stay | 11 | 2018 | 811 | 0.930 |
Why?
|
| Aged, 80 and over | 42 | 2021 | 5449 | 0.910 |
Why?
|
| Organizational Culture | 11 | 2016 | 110 | 0.910 |
Why?
|
| Data Mining | 2 | 2016 | 38 | 0.900 |
Why?
|
| Research Design | 10 | 2011 | 573 | 0.890 |
Why?
|
| Hospitals, Teaching | 10 | 2013 | 105 | 0.880 |
Why?
|
| Health Care Costs | 4 | 2020 | 210 | 0.880 |
Why?
|
| Medical Records Systems, Computerized | 9 | 2011 | 62 | 0.860 |
Why?
|
| Joint Prosthesis | 2 | 2023 | 6 | 0.850 |
Why?
|
| Reimbursement, Incentive | 4 | 2016 | 29 | 0.840 |
Why?
|
| Cataract Extraction | 2 | 2021 | 36 | 0.840 |
Why?
|
| Substance-Related Disorders | 7 | 2021 | 733 | 0.840 |
Why?
|
| Temporomandibular Joint | 1 | 2023 | 2 | 0.810 |
Why?
|
| Delivery of Health Care, Integrated | 7 | 2020 | 121 | 0.810 |
Why?
|
| Mental Health Services | 8 | 2024 | 287 | 0.800 |
Why?
|
| Prisoners | 2 | 2021 | 165 | 0.780 |
Why?
|
| Myocardial Infarction | 11 | 2016 | 913 | 0.780 |
Why?
|
| Comorbidity | 14 | 2022 | 1123 | 0.750 |
Why?
|
| Iatrogenic Disease | 3 | 2011 | 60 | 0.740 |
Why?
|
| Venous Thrombosis | 4 | 2018 | 115 | 0.730 |
Why?
|
| Socioeconomic Factors | 10 | 2020 | 777 | 0.710 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2021 | 11 | 0.710 |
Why?
|
| Medical Staff, Hospital | 5 | 2016 | 57 | 0.710 |
Why?
|
| Venous Thromboembolism | 4 | 2018 | 149 | 0.710 |
Why?
|
| Pneumonia | 7 | 2016 | 290 | 0.690 |
Why?
|
| Interviews as Topic | 8 | 2024 | 510 | 0.690 |
Why?
|
| Adult | 63 | 2024 | 16794 | 0.680 |
Why?
|
| Potentially Inappropriate Medication List | 2 | 2022 | 15 | 0.680 |
Why?
|
| Health Priorities | 1 | 2020 | 28 | 0.680 |
Why?
|
| Organizational Objectives | 1 | 2020 | 59 | 0.670 |
Why?
|
| Intellectual Disability | 2 | 2014 | 172 | 0.660 |
Why?
|
| False Positive Reactions | 10 | 2011 | 78 | 0.650 |
Why?
|
| Internship and Residency | 11 | 2016 | 800 | 0.650 |
Why?
|
| Logistic Models | 22 | 2020 | 1274 | 0.650 |
Why?
|
| Models, Organizational | 3 | 2016 | 93 | 0.640 |
Why?
|
| Health Status | 8 | 2018 | 435 | 0.640 |
Why?
|
| Pharmacies | 2 | 2019 | 36 | 0.640 |
Why?
|
| Deprescriptions | 3 | 2025 | 25 | 0.640 |
Why?
|
| Personnel Staffing and Scheduling | 9 | 2013 | 66 | 0.630 |
Why?
|
| Nursing Staff, Hospital | 4 | 2014 | 67 | 0.630 |
Why?
|
| Health Plan Implementation | 3 | 2021 | 40 | 0.630 |
Why?
|
| American Hospital Association | 1 | 2019 | 3 | 0.630 |
Why?
|
| Safety | 4 | 2011 | 145 | 0.620 |
Why?
|
| Healthcare Disparities | 6 | 2024 | 359 | 0.620 |
Why?
|
| Prescription Drugs | 1 | 2019 | 51 | 0.610 |
Why?
|
| Safety-net Providers | 1 | 2019 | 30 | 0.610 |
Why?
|
| Surgery Department, Hospital | 3 | 2020 | 21 | 0.610 |
Why?
|
| Severity of Illness Index | 11 | 2020 | 1542 | 0.600 |
Why?
|
| Commerce | 3 | 2017 | 56 | 0.570 |
Why?
|
| Hospital Administrators | 1 | 2018 | 10 | 0.570 |
Why?
|
| Sepsis | 3 | 2011 | 286 | 0.550 |
Why?
|
| Cost of Illness | 3 | 2015 | 162 | 0.540 |
Why?
|
| Electronic Health Records | 7 | 2016 | 360 | 0.530 |
Why?
|
| Hospitalization | 10 | 2020 | 1359 | 0.520 |
Why?
|
| Health Resources | 3 | 2003 | 94 | 0.510 |
Why?
|
| Efficiency, Organizational | 4 | 2013 | 96 | 0.510 |
Why?
|
| Early Detection of Cancer | 3 | 2020 | 319 | 0.510 |
Why?
|
| Ankle Joint | 1 | 2016 | 46 | 0.500 |
Why?
|
| Qualitative Research | 4 | 2024 | 684 | 0.500 |
Why?
|
| Joint Instability | 1 | 2016 | 53 | 0.490 |
Why?
|
| Heart Failure | 6 | 2016 | 915 | 0.490 |
Why?
|
| Breast Neoplasms | 4 | 2015 | 1195 | 0.490 |
Why?
|
| Terminology as Topic | 1 | 2017 | 141 | 0.490 |
Why?
|
| Health Services | 3 | 2010 | 82 | 0.490 |
Why?
|
| Physician Incentive Plans | 1 | 2015 | 9 | 0.490 |
Why?
|
| Personnel, Hospital | 6 | 2014 | 43 | 0.480 |
Why?
|
| Software | 3 | 2016 | 388 | 0.480 |
Why?
|
| Anticoagulants | 4 | 2018 | 495 | 0.480 |
Why?
|
| Program Evaluation | 8 | 2018 | 487 | 0.470 |
Why?
|
| Observer Variation | 7 | 2012 | 213 | 0.470 |
Why?
|
| Patient Education as Topic | 3 | 2025 | 474 | 0.460 |
Why?
|
| Cooperative Behavior | 2 | 2014 | 222 | 0.460 |
Why?
|
| Regression Analysis | 10 | 2020 | 498 | 0.460 |
Why?
|
| Patient Care Team | 3 | 2014 | 337 | 0.450 |
Why?
|
| Cohort Studies | 18 | 2022 | 2569 | 0.450 |
Why?
|
| Episode of Care | 4 | 1999 | 8 | 0.450 |
Why?
|
| Attitude of Health Personnel | 8 | 2016 | 595 | 0.450 |
Why?
|
| Psychotic Disorders | 2 | 2012 | 158 | 0.440 |
Why?
|
| Hospital Costs | 2 | 2014 | 126 | 0.430 |
Why?
|
| Hospital Records | 2 | 2013 | 8 | 0.430 |
Why?
|
| Acute Kidney Injury | 2 | 2018 | 146 | 0.430 |
Why?
|
| Catheterization, Central Venous | 2 | 2013 | 87 | 0.430 |
Why?
|
| Intraoperative Complications | 4 | 2021 | 91 | 0.430 |
Why?
|
| Treatment Outcome | 19 | 2022 | 5660 | 0.430 |
Why?
|
| Workload | 2 | 2014 | 126 | 0.400 |
Why?
|
| Waiting Lists | 2 | 2023 | 51 | 0.400 |
Why?
|
| Interdisciplinary Communication | 1 | 2013 | 105 | 0.390 |
Why?
|
| Hospital Bed Capacity | 2 | 2009 | 27 | 0.390 |
Why?
|
| Mastectomy, Segmental | 1 | 2013 | 46 | 0.390 |
Why?
|
| Surgicenters | 3 | 2020 | 6 | 0.390 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 116 | 0.390 |
Why?
|
| Problem-Based Learning | 1 | 2013 | 37 | 0.390 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 834 | 0.380 |
Why?
|
| Time Factors | 13 | 2021 | 3763 | 0.380 |
Why?
|
| Insurance Coverage | 3 | 2021 | 100 | 0.370 |
Why?
|
| Adolescent | 20 | 2020 | 6247 | 0.360 |
Why?
|
| Continuity of Patient Care | 4 | 2015 | 174 | 0.360 |
Why?
|
| Mental Health | 2 | 2017 | 371 | 0.360 |
Why?
|
| Validation Studies as Topic | 1 | 2011 | 20 | 0.360 |
Why?
|
| Delivery of Health Care | 4 | 2022 | 435 | 0.350 |
Why?
|
| Medication Errors | 2 | 2011 | 109 | 0.350 |
Why?
|
| Cholecystectomy | 4 | 2021 | 34 | 0.350 |
Why?
|
| Postoperative Hemorrhage | 1 | 2011 | 40 | 0.340 |
Why?
|
| Nursing Homes | 5 | 2006 | 670 | 0.340 |
Why?
|
| Surgical Wound Infection | 4 | 2019 | 115 | 0.340 |
Why?
|
| Work Schedule Tolerance | 6 | 2014 | 22 | 0.340 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2011 | 72 | 0.340 |
Why?
|
| Hematoma | 1 | 2011 | 80 | 0.340 |
Why?
|
| Diabetes Complications | 1 | 2011 | 106 | 0.340 |
Why?
|
| Surveys and Questionnaires | 11 | 2022 | 2674 | 0.330 |
Why?
|
| Long-Term Care | 3 | 2001 | 177 | 0.330 |
Why?
|
| Models, Statistical | 7 | 2014 | 308 | 0.330 |
Why?
|
| Community Mental Health Services | 3 | 2017 | 94 | 0.330 |
Why?
|
| Consensus | 3 | 2018 | 227 | 0.330 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 2 | 2011 | 144 | 0.330 |
Why?
|
| Activities of Daily Living | 5 | 2011 | 291 | 0.330 |
Why?
|
| Health Care Surveys | 8 | 2021 | 286 | 0.330 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 158 | 0.320 |
Why?
|
| Patient Freedom of Choice Laws | 4 | 2021 | 4 | 0.320 |
Why?
|
| Outpatients | 2 | 2021 | 142 | 0.320 |
Why?
|
| Physician-Patient Relations | 3 | 2025 | 419 | 0.320 |
Why?
|
| Accreditation | 5 | 2019 | 77 | 0.310 |
Why?
|
| Population Surveillance | 4 | 2015 | 206 | 0.300 |
Why?
|
| Mammography | 1 | 2011 | 280 | 0.300 |
Why?
|
| Residence Characteristics | 6 | 2020 | 220 | 0.300 |
Why?
|
| Medical Audit | 4 | 2015 | 65 | 0.300 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2024 | 479 | 0.300 |
Why?
|
| Young Adult | 9 | 2020 | 4687 | 0.290 |
Why?
|
| Neoplasms | 2 | 2020 | 1361 | 0.290 |
Why?
|
| Multivariate Analysis | 8 | 2019 | 936 | 0.290 |
Why?
|
| Models, Econometric | 2 | 2006 | 14 | 0.270 |
Why?
|
| Drug Utilization Review | 5 | 2008 | 52 | 0.270 |
Why?
|
| Communication | 3 | 2018 | 571 | 0.270 |
Why?
|
| Pain, Postoperative | 2 | 2019 | 163 | 0.270 |
Why?
|
| Guideline Adherence | 3 | 2019 | 305 | 0.260 |
Why?
|
| Patient Participation | 2 | 2025 | 230 | 0.260 |
Why?
|
| Documentation | 4 | 2016 | 128 | 0.260 |
Why?
|
| Neoplasm Staging | 3 | 2020 | 501 | 0.250 |
Why?
|
| Surgeons | 3 | 2018 | 181 | 0.250 |
Why?
|
| Catheter-Related Infections | 3 | 2017 | 42 | 0.250 |
Why?
|
| Sensitivity and Specificity | 6 | 2018 | 1146 | 0.250 |
Why?
|
| Preoperative Period | 4 | 2019 | 71 | 0.250 |
Why?
|
| Concurrent Review | 2 | 2002 | 3 | 0.250 |
Why?
|
| Likelihood Functions | 3 | 2013 | 69 | 0.240 |
Why?
|
| Practice Guidelines as Topic | 5 | 2019 | 734 | 0.240 |
Why?
|
| Intensive Care Units | 2 | 2015 | 406 | 0.230 |
Why?
|
| Feasibility Studies | 4 | 2020 | 568 | 0.220 |
Why?
|
| Delphi Technique | 4 | 2016 | 101 | 0.220 |
Why?
|
| Linear Models | 3 | 2016 | 409 | 0.220 |
Why?
|
| Age Distribution | 4 | 2013 | 259 | 0.210 |
Why?
|
| Emergency Service, Hospital | 3 | 2021 | 1100 | 0.210 |
Why?
|
| Residential Facilities | 3 | 2014 | 19 | 0.210 |
Why?
|
| Managed Care Programs | 3 | 2003 | 89 | 0.210 |
Why?
|
| Analgesics, Opioid | 2 | 2019 | 536 | 0.210 |
Why?
|
| Urban Population | 2 | 2021 | 193 | 0.210 |
Why?
|
| Spinal Cord Diseases | 1 | 2004 | 39 | 0.210 |
Why?
|
| Pressure Ulcer | 2 | 2013 | 34 | 0.210 |
Why?
|
| Resource Allocation | 1 | 2003 | 19 | 0.210 |
Why?
|
| Asthma | 2 | 1998 | 440 | 0.200 |
Why?
|
| Pilot Projects | 6 | 2022 | 1007 | 0.200 |
Why?
|
| Critical Care | 1 | 2007 | 397 | 0.200 |
Why?
|
| Natural Language Processing | 2 | 2015 | 48 | 0.200 |
Why?
|
| Sentinel Surveillance | 2 | 2017 | 19 | 0.200 |
Why?
|
| Self Report | 2 | 2016 | 375 | 0.200 |
Why?
|
| Meta-Analysis as Topic | 1 | 2023 | 77 | 0.200 |
Why?
|
| Community Networks | 1 | 2002 | 31 | 0.200 |
Why?
|
| Substance Abuse Treatment Centers | 2 | 2002 | 104 | 0.190 |
Why?
|
| Smoking Prevention | 5 | 1995 | 162 | 0.190 |
Why?
|
| Lacerations | 2 | 2012 | 15 | 0.180 |
Why?
|
| Checklist | 2 | 2014 | 73 | 0.180 |
Why?
|
| Hospitals, Urban | 1 | 2021 | 43 | 0.180 |
Why?
|
| Stroke | 4 | 2010 | 1192 | 0.180 |
Why?
|
| Medical Record Linkage | 3 | 2015 | 21 | 0.180 |
Why?
|
| Patients | 2 | 2009 | 113 | 0.180 |
Why?
|
| Survival Analysis | 3 | 2013 | 581 | 0.170 |
Why?
|
| Health Policy | 2 | 2021 | 191 | 0.170 |
Why?
|
| Drug Prescriptions | 4 | 2007 | 168 | 0.170 |
Why?
|
| Patient Care | 3 | 2010 | 80 | 0.170 |
Why?
|
| Bias | 2 | 2018 | 112 | 0.170 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2020 | 39 | 0.170 |
Why?
|
| Massachusetts | 6 | 2014 | 2076 | 0.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2015 | 762 | 0.170 |
Why?
|
| Data Interpretation, Statistical | 2 | 1999 | 194 | 0.170 |
Why?
|
| Health Expenditures | 3 | 2015 | 122 | 0.170 |
Why?
|
| Forecasting | 2 | 2020 | 232 | 0.170 |
Why?
|
| Health Services Needs and Demand | 3 | 2017 | 209 | 0.160 |
Why?
|
| Risk Assessment | 7 | 2018 | 2077 | 0.160 |
Why?
|
| Digestive System Surgical Procedures | 2 | 2018 | 90 | 0.160 |
Why?
|
| Coronary Artery Bypass | 6 | 1999 | 297 | 0.160 |
Why?
|
| Prospective Studies | 10 | 2019 | 3285 | 0.160 |
Why?
|
| Antidepressive Agents | 4 | 2005 | 225 | 0.160 |
Why?
|
| Postoperative Period | 3 | 2018 | 138 | 0.160 |
Why?
|
| Depressive Disorder | 4 | 2004 | 284 | 0.160 |
Why?
|
| Polypharmacy | 1 | 2019 | 61 | 0.160 |
Why?
|
| Hip Dislocation, Congenital | 1 | 1999 | 3 | 0.160 |
Why?
|
| Software Validation | 1 | 1999 | 9 | 0.150 |
Why?
|
| Organizational Policy | 4 | 2015 | 52 | 0.150 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2019 | 55 | 0.150 |
Why?
|
| Kidney Transplantation | 4 | 2002 | 319 | 0.150 |
Why?
|
| Proteinuria | 1 | 2018 | 41 | 0.150 |
Why?
|
| Consumer Behavior | 1 | 2018 | 36 | 0.150 |
Why?
|
| Pneumothorax | 2 | 2010 | 50 | 0.150 |
Why?
|
| Mortality | 4 | 2020 | 160 | 0.150 |
Why?
|
| Professional Role | 1 | 2018 | 43 | 0.140 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2018 | 64 | 0.140 |
Why?
|
| Stakeholder Participation | 1 | 2018 | 23 | 0.140 |
Why?
|
| Prevalence | 3 | 2019 | 1378 | 0.140 |
Why?
|
| Risk Management | 1 | 2018 | 39 | 0.140 |
Why?
|
| Psychopathology | 1 | 2017 | 21 | 0.140 |
Why?
|
| Pandemics | 1 | 2023 | 672 | 0.140 |
Why?
|
| Drug Utilization | 1 | 2019 | 209 | 0.140 |
Why?
|
| New England | 4 | 2013 | 273 | 0.140 |
Why?
|
| Fee-for-Service Plans | 1 | 1998 | 69 | 0.140 |
Why?
|
| Esophagectomy | 1 | 2018 | 48 | 0.140 |
Why?
|
| Incidence | 3 | 2018 | 1376 | 0.130 |
Why?
|
| Recovery of Function | 1 | 1999 | 287 | 0.130 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2017 | 102 | 0.130 |
Why?
|
| Pneumonectomy | 1 | 2018 | 109 | 0.130 |
Why?
|
| Esophageal Neoplasms | 1 | 2018 | 83 | 0.130 |
Why?
|
| Ankle Injuries | 1 | 2016 | 10 | 0.130 |
Why?
|
| Needs Assessment | 1 | 2018 | 198 | 0.130 |
Why?
|
| Evidence-Based Medicine | 2 | 2019 | 462 | 0.130 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 48 | 0.130 |
Why?
|
| Hernia, Inguinal | 1 | 2016 | 42 | 0.130 |
Why?
|
| Truth Disclosure | 1 | 2016 | 57 | 0.130 |
Why?
|
| Health Records, Personal | 1 | 2016 | 26 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 1 | 2017 | 181 | 0.130 |
Why?
|
| Range of Motion, Articular | 1 | 2016 | 104 | 0.120 |
Why?
|
| Quality of Life | 3 | 2017 | 1225 | 0.120 |
Why?
|
| Organizational Innovation | 1 | 2016 | 82 | 0.120 |
Why?
|
| Thiophenes | 2 | 2006 | 29 | 0.120 |
Why?
|
| Data Collection | 2 | 2017 | 383 | 0.120 |
Why?
|
| Patient Portals | 1 | 2016 | 49 | 0.120 |
Why?
|
| Geriatrics | 2 | 2008 | 43 | 0.120 |
Why?
|
| Bariatric Surgery | 1 | 2016 | 60 | 0.120 |
Why?
|
| Software Design | 1 | 2015 | 28 | 0.120 |
Why?
|
| Information Dissemination | 1 | 2016 | 116 | 0.120 |
Why?
|
| Computer Systems | 1 | 2015 | 14 | 0.120 |
Why?
|
| Reproduction | 1 | 1996 | 92 | 0.120 |
Why?
|
| Age Factors | 4 | 2012 | 1558 | 0.120 |
Why?
|
| Odds Ratio | 3 | 2014 | 768 | 0.120 |
Why?
|
| Comprehensive Health Care | 1 | 2015 | 19 | 0.120 |
Why?
|
| Angioplasty, Balloon, Coronary | 4 | 1999 | 168 | 0.120 |
Why?
|
| Registries | 2 | 2013 | 887 | 0.120 |
Why?
|
| Opioid-Related Disorders | 2 | 2019 | 507 | 0.120 |
Why?
|
| Diffusion of Innovation | 2 | 2013 | 58 | 0.110 |
Why?
|
| Follow-Up Studies | 8 | 2018 | 2457 | 0.110 |
Why?
|
| Systems Analysis | 2 | 2013 | 10 | 0.110 |
Why?
|
| Obesity, Morbid | 1 | 2016 | 98 | 0.110 |
Why?
|
| Homes for the Aged | 2 | 2005 | 161 | 0.110 |
Why?
|
| Patient Admission | 1 | 2016 | 197 | 0.110 |
Why?
|
| New York | 6 | 2020 | 144 | 0.110 |
Why?
|
| Suburban Population | 1 | 1994 | 9 | 0.110 |
Why?
|
| Mobile Health Units | 1 | 1994 | 11 | 0.110 |
Why?
|
| Maternal Health Services | 1 | 2015 | 66 | 0.110 |
Why?
|
| Sampling Studies | 2 | 2005 | 70 | 0.110 |
Why?
|
| Self Care | 1 | 2016 | 212 | 0.110 |
Why?
|
| Remission Induction | 1 | 2014 | 148 | 0.110 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 90 | 0.110 |
Why?
|
| Reimbursement Mechanisms | 1 | 2014 | 40 | 0.110 |
Why?
|
| Aortic Rupture | 1 | 2014 | 54 | 0.110 |
Why?
|
| Knee Joint | 1 | 2016 | 298 | 0.110 |
Why?
|
| Pregnancy Outcome | 1 | 2015 | 194 | 0.110 |
Why?
|
| Women's Health | 2 | 2015 | 370 | 0.110 |
Why?
|
| Rubber | 1 | 1993 | 3 | 0.110 |
Why?
|
| Gloves, Surgical | 1 | 1993 | 3 | 0.110 |
Why?
|
| Health Promotion | 2 | 2015 | 497 | 0.110 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1993 | 6 | 0.110 |
Why?
|
| Dermatitis, Occupational | 1 | 1993 | 4 | 0.110 |
Why?
|
| Prenatal Care | 1 | 2015 | 170 | 0.110 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2019 | 712 | 0.110 |
Why?
|
| Spirometry | 1 | 2014 | 111 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2016 | 1120 | 0.100 |
Why?
|
| Mandatory Reporting | 1 | 2013 | 16 | 0.100 |
Why?
|
| Mastectomy, Modified Radical | 1 | 2013 | 1 | 0.100 |
Why?
|
| Private Sector | 1 | 2013 | 12 | 0.100 |
Why?
|
| Feedback | 1 | 2013 | 93 | 0.100 |
Why?
|
| Acute Disease | 3 | 2012 | 672 | 0.100 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2013 | 42 | 0.100 |
Why?
|
| False Negative Reactions | 1 | 2013 | 41 | 0.100 |
Why?
|
| SEER Program | 1 | 2013 | 74 | 0.100 |
Why?
|
| Abdominal Wall | 1 | 2013 | 23 | 0.100 |
Why?
|
| Wounds and Injuries | 2 | 2017 | 247 | 0.100 |
Why?
|
| Raloxifene Hydrochloride | 2 | 2003 | 18 | 0.100 |
Why?
|
| Health Care Reform | 2 | 2014 | 87 | 0.100 |
Why?
|
| Boston | 2 | 2012 | 252 | 0.100 |
Why?
|
| Internal Medicine | 1 | 2014 | 160 | 0.100 |
Why?
|
| Accidents | 1 | 2012 | 14 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 3 | 2000 | 341 | 0.100 |
Why?
|
| Total Quality Management | 2 | 2004 | 56 | 0.100 |
Why?
|
| Wounds, Penetrating | 1 | 2012 | 26 | 0.100 |
Why?
|
| Sex Factors | 3 | 2012 | 979 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 196 | 0.090 |
Why?
|
| Social Support | 2 | 2000 | 371 | 0.090 |
Why?
|
| Diet | 1 | 1996 | 524 | 0.090 |
Why?
|
| Alzheimer Disease | 2 | 2011 | 721 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2012 | 253 | 0.090 |
Why?
|
| Peripheral Arterial Disease | 1 | 2014 | 172 | 0.090 |
Why?
|
| Tacrolimus | 2 | 2002 | 65 | 0.090 |
Why?
|
| Mycophenolic Acid | 2 | 2002 | 68 | 0.090 |
Why?
|
| Estradiol | 2 | 2003 | 257 | 0.090 |
Why?
|
| Fungemia | 1 | 2011 | 6 | 0.090 |
Why?
|
| Vascular Surgical Procedures | 1 | 2014 | 261 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 668 | 0.090 |
Why?
|
| Postmenopause | 2 | 2003 | 237 | 0.090 |
Why?
|
| Blood Coagulation Factors | 1 | 2011 | 16 | 0.090 |
Why?
|
| Evaluation Studies as Topic | 3 | 2001 | 104 | 0.090 |
Why?
|
| Information Storage and Retrieval | 1 | 2011 | 60 | 0.090 |
Why?
|
| Bipolar Disorder | 2 | 2009 | 247 | 0.090 |
Why?
|
| Cardiac Catheterization | 2 | 2004 | 281 | 0.090 |
Why?
|
| Ear Diseases | 2 | 2001 | 12 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 2 | 2001 | 139 | 0.090 |
Why?
|
| Bile Ducts, Intrahepatic | 2 | 2001 | 26 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2011 | 37 | 0.090 |
Why?
|
| Child | 4 | 2017 | 4531 | 0.090 |
Why?
|
| Medical Records | 1 | 2011 | 137 | 0.090 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2014 | 249 | 0.090 |
Why?
|
| California | 1 | 2011 | 174 | 0.090 |
Why?
|
| Deinstitutionalization | 2 | 2001 | 9 | 0.090 |
Why?
|
| Cholangiocarcinoma | 2 | 2001 | 31 | 0.090 |
Why?
|
| Psychometrics | 3 | 2009 | 376 | 0.090 |
Why?
|
| Memantine | 1 | 2011 | 23 | 0.090 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2014 | 310 | 0.090 |
Why?
|
| Morbidity | 2 | 2018 | 113 | 0.080 |
Why?
|
| Lower Extremity | 2 | 2014 | 166 | 0.080 |
Why?
|
| Foreign Bodies | 1 | 2011 | 55 | 0.080 |
Why?
|
| Bile Duct Neoplasms | 2 | 2001 | 54 | 0.080 |
Why?
|
| Aviation | 1 | 2010 | 4 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2016 | 695 | 0.080 |
Why?
|
| Community-Acquired Infections | 1 | 2011 | 94 | 0.080 |
Why?
|
| Bacteremia | 1 | 2011 | 94 | 0.080 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2010 | 78 | 0.080 |
Why?
|
| Pancreatic Cyst | 2 | 2000 | 24 | 0.080 |
Why?
|
| Fatigue | 1 | 2010 | 111 | 0.080 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 294 | 0.080 |
Why?
|
| Immunoglobulin G | 2 | 2002 | 459 | 0.080 |
Why?
|
| Immunosuppressive Agents | 2 | 2002 | 377 | 0.080 |
Why?
|
| Gulf War | 1 | 2009 | 5 | 0.080 |
Why?
|
| Analysis of Variance | 3 | 2000 | 608 | 0.080 |
Why?
|
| Social Environment | 2 | 1991 | 93 | 0.080 |
Why?
|
| Health Facility Environment | 1 | 2009 | 3 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2010 | 143 | 0.080 |
Why?
|
| Factor Analysis, Statistical | 1 | 2009 | 97 | 0.080 |
Why?
|
| Single Person | 1 | 1989 | 4 | 0.080 |
Why?
|
| Job Satisfaction | 2 | 2008 | 137 | 0.080 |
Why?
|
| Pregnancy | 2 | 2015 | 2333 | 0.080 |
Why?
|
| Patient Satisfaction | 3 | 2017 | 433 | 0.070 |
Why?
|
| Fecal Incontinence | 1 | 2009 | 30 | 0.070 |
Why?
|
| Rectal Fistula | 1 | 2009 | 21 | 0.070 |
Why?
|
| Patient-Centered Care | 1 | 2011 | 254 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2009 | 72 | 0.070 |
Why?
|
| Operating Rooms | 1 | 2009 | 55 | 0.070 |
Why?
|
| Utilization Review | 2 | 1999 | 32 | 0.070 |
Why?
|
| Postoperative Care | 1 | 2009 | 123 | 0.070 |
Why?
|
| Smoking Cessation | 3 | 1992 | 550 | 0.070 |
Why?
|
| Religion | 1 | 2008 | 30 | 0.070 |
Why?
|
| Empirical Research | 1 | 2008 | 15 | 0.070 |
Why?
|
| Coronary Disease | 3 | 1999 | 246 | 0.070 |
Why?
|
| Suture Techniques | 1 | 2009 | 100 | 0.070 |
Why?
|
| Drainage | 1 | 2009 | 154 | 0.070 |
Why?
|
| Physicians, Family | 1 | 2008 | 74 | 0.070 |
Why?
|
| Pain Measurement | 2 | 2006 | 345 | 0.070 |
Why?
|
| Health Services for the Aged | 1 | 2008 | 49 | 0.070 |
Why?
|
| Drug Therapy | 1 | 2008 | 56 | 0.070 |
Why?
|
| Tertiary Care Centers | 2 | 2020 | 108 | 0.070 |
Why?
|
| Endovascular Procedures | 1 | 2014 | 649 | 0.070 |
Why?
|
| Glucocorticoids | 2 | 2017 | 188 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2009 | 146 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 863 | 0.070 |
Why?
|
| Normal Distribution | 1 | 2006 | 17 | 0.070 |
Why?
|
| Adaptation, Psychological | 1 | 1989 | 265 | 0.070 |
Why?
|
| Minority Groups | 2 | 2002 | 139 | 0.060 |
Why?
|
| Workplace | 1 | 2008 | 172 | 0.060 |
Why?
|
| Diabetic Neuropathies | 1 | 2006 | 7 | 0.060 |
Why?
|
| Pain Threshold | 1 | 2006 | 25 | 0.060 |
Why?
|
| Job Description | 1 | 2006 | 24 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2006 | 240 | 0.060 |
Why?
|
| Eligibility Determination | 2 | 2021 | 36 | 0.060 |
Why?
|
| Analgesia | 1 | 2006 | 31 | 0.060 |
Why?
|
| Health Surveys | 3 | 2017 | 313 | 0.060 |
Why?
|
| Fibromyalgia | 1 | 2005 | 15 | 0.060 |
Why?
|
| Nursing Staff | 1 | 2006 | 40 | 0.060 |
Why?
|
| Anxiety | 1 | 2009 | 423 | 0.060 |
Why?
|
| Demography | 2 | 2016 | 173 | 0.060 |
Why?
|
| Reoperation | 4 | 2014 | 289 | 0.060 |
Why?
|
| Decision Making, Organizational | 1 | 2005 | 26 | 0.060 |
Why?
|
| Pamphlets | 1 | 2025 | 16 | 0.060 |
Why?
|
| Management Information Systems | 2 | 2002 | 2 | 0.060 |
Why?
|
| Myocardial Ischemia | 2 | 2004 | 118 | 0.060 |
Why?
|
| Double-Blind Method | 4 | 2011 | 738 | 0.060 |
Why?
|
| Learning | 1 | 2006 | 182 | 0.060 |
Why?
|
| Patient Care Bundles | 1 | 2024 | 12 | 0.060 |
Why?
|
| Clinical Competence | 3 | 2018 | 725 | 0.060 |
Why?
|
| Florida | 2 | 2020 | 48 | 0.060 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2009 | 397 | 0.060 |
Why?
|
| Medicaid | 2 | 2020 | 362 | 0.050 |
Why?
|
| Prognosis | 2 | 2018 | 1747 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2008 | 263 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 2007 | 264 | 0.050 |
Why?
|
| Graft Survival | 2 | 2001 | 290 | 0.050 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 2003 | 9 | 0.050 |
Why?
|
| Database Management Systems | 1 | 2003 | 19 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 2 | 2006 | 311 | 0.050 |
Why?
|
| Brain Mapping | 2 | 2017 | 232 | 0.050 |
Why?
|
| Psychology | 1 | 2003 | 45 | 0.050 |
Why?
|
| Crohn Disease | 3 | 2017 | 111 | 0.050 |
Why?
|
| Prostatectomy | 2 | 1995 | 99 | 0.050 |
Why?
|
| Endoscopy | 2 | 2001 | 110 | 0.050 |
Why?
|
| Estrogen Antagonists | 1 | 2003 | 16 | 0.050 |
Why?
|
| Synovitis | 2 | 2000 | 30 | 0.050 |
Why?
|
| Survival Rate | 4 | 2002 | 851 | 0.050 |
Why?
|
| Depressive Disorder, Major | 1 | 2005 | 255 | 0.050 |
Why?
|
| Random Allocation | 1 | 2003 | 199 | 0.050 |
Why?
|
| Graft Rejection | 2 | 2002 | 293 | 0.050 |
Why?
|
| Decision Making | 2 | 2002 | 407 | 0.050 |
Why?
|
| Capitation Fee | 1 | 2002 | 8 | 0.050 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2002 | 17 | 0.050 |
Why?
|
| Attitude to Health | 1 | 2004 | 289 | 0.050 |
Why?
|
| Chi-Square Distribution | 3 | 2002 | 417 | 0.050 |
Why?
|
| Vagina | 1 | 2003 | 83 | 0.050 |
Why?
|
| Infant | 2 | 2015 | 1650 | 0.050 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 539 | 0.050 |
Why?
|
| Risk | 1 | 2003 | 377 | 0.050 |
Why?
|
| Income | 2 | 2016 | 169 | 0.050 |
Why?
|
| Social Determinants of Health | 1 | 2024 | 131 | 0.050 |
Why?
|
| Proton Pump Inhibitors | 1 | 2022 | 42 | 0.050 |
Why?
|
| Depression | 1 | 1989 | 892 | 0.050 |
Why?
|
| Hot Flashes | 1 | 2003 | 100 | 0.040 |
Why?
|
| Geography | 1 | 2021 | 37 | 0.040 |
Why?
|
| Bone Conduction | 1 | 2001 | 7 | 0.040 |
Why?
|
| Laparoscopy | 3 | 2000 | 491 | 0.040 |
Why?
|
| Health Behavior | 2 | 2003 | 469 | 0.040 |
Why?
|
| Australia | 2 | 2017 | 120 | 0.040 |
Why?
|
| Chimera | 1 | 2000 | 42 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 2001 | 34 | 0.040 |
Why?
|
| Eustachian Tube | 1 | 2000 | 8 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2021 | 123 | 0.040 |
Why?
|
| Frail Elderly | 1 | 2001 | 109 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2000 | 18 | 0.040 |
Why?
|
| Social Class | 1 | 2021 | 133 | 0.040 |
Why?
|
| Automobile Driving | 1 | 2021 | 54 | 0.040 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2000 | 5 | 0.040 |
Why?
|
| Radiography | 2 | 1999 | 548 | 0.040 |
Why?
|
| Calibration | 1 | 2000 | 66 | 0.040 |
Why?
|
| Laparoscopes | 1 | 2000 | 25 | 0.040 |
Why?
|
| Endosonography | 1 | 2000 | 26 | 0.040 |
Why?
|
| Perception | 1 | 2021 | 174 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2000 | 50 | 0.040 |
Why?
|
| Insurance, Health | 1 | 2001 | 152 | 0.040 |
Why?
|
| Narcotics | 1 | 2000 | 58 | 0.040 |
Why?
|
| Sweating, Gustatory | 1 | 1999 | 1 | 0.040 |
Why?
|
| Parotid Gland | 1 | 1999 | 11 | 0.040 |
Why?
|
| Manipulation, Orthopedic | 1 | 1999 | 6 | 0.040 |
Why?
|
| Braces | 1 | 1999 | 10 | 0.040 |
Why?
|
| Diabetic Retinopathy | 1 | 2000 | 53 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2000 | 182 | 0.040 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2000 | 335 | 0.040 |
Why?
|
| Antimicrobial Stewardship | 1 | 2019 | 16 | 0.040 |
Why?
|
| Methadone | 1 | 2000 | 134 | 0.040 |
Why?
|
| Arthroplasty, Replacement | 1 | 1999 | 17 | 0.040 |
Why?
|
| Wrist Joint | 1 | 1999 | 25 | 0.040 |
Why?
|
| Wounds, Gunshot | 1 | 1999 | 56 | 0.040 |
Why?
|
| Prosthesis Failure | 1 | 1999 | 74 | 0.040 |
Why?
|
| Colorectal Surgery | 1 | 2019 | 51 | 0.040 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 72 | 0.040 |
Why?
|
| Longitudinal Studies | 3 | 2011 | 1255 | 0.040 |
Why?
|
| Insurance Claim Reporting | 1 | 1998 | 17 | 0.040 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 113 | 0.040 |
Why?
|
| Surgical Flaps | 1 | 1999 | 118 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2000 | 390 | 0.040 |
Why?
|
| Complementary Therapies | 1 | 1998 | 62 | 0.030 |
Why?
|
| Colitis, Ulcerative | 2 | 2017 | 74 | 0.030 |
Why?
|
| Philadelphia | 1 | 2017 | 21 | 0.030 |
Why?
|
| Ulna Fractures | 1 | 1997 | 6 | 0.030 |
Why?
|
| Fractures, Stress | 1 | 1997 | 12 | 0.030 |
Why?
|
| Biomarkers | 2 | 2017 | 1397 | 0.030 |
Why?
|
| Data Accuracy | 1 | 2017 | 32 | 0.030 |
Why?
|
| Gyrus Cinguli | 1 | 2017 | 57 | 0.030 |
Why?
|
| Disease Management | 1 | 1999 | 232 | 0.030 |
Why?
|
| Cadaver | 3 | 2002 | 128 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2001 | 1995 | 0.030 |
Why?
|
| Operating Room Nursing | 1 | 2016 | 4 | 0.030 |
Why?
|
| Colonic Pouches | 1 | 2017 | 16 | 0.030 |
Why?
|
| Colostomy | 1 | 2017 | 24 | 0.030 |
Why?
|
| Gastroenterologists | 1 | 2016 | 10 | 0.030 |
Why?
|
| Anesthesiologists | 1 | 2016 | 18 | 0.030 |
Why?
|
| Prednisone | 1 | 2017 | 86 | 0.030 |
Why?
|
| Athletic Injuries | 1 | 1997 | 83 | 0.030 |
Why?
|
| Operative Time | 1 | 2016 | 92 | 0.030 |
Why?
|
| Anesthesia | 1 | 2016 | 50 | 0.030 |
Why?
|
| Duloxetine Hydrochloride | 2 | 2006 | 3 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2018 | 202 | 0.030 |
Why?
|
| Placebo Effect | 2 | 2006 | 10 | 0.030 |
Why?
|
| Rectum | 1 | 2017 | 89 | 0.030 |
Why?
|
| Medical Informatics | 1 | 2016 | 73 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 156 | 0.030 |
Why?
|
| Poverty | 1 | 2018 | 296 | 0.030 |
Why?
|
| Brain | 3 | 2017 | 1553 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 260 | 0.030 |
Why?
|
| Colectomy | 1 | 2017 | 108 | 0.030 |
Why?
|
| Emigration and Immigration | 1 | 1996 | 27 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2016 | 158 | 0.030 |
Why?
|
| Poisson Distribution | 1 | 2015 | 53 | 0.030 |
Why?
|
| Students, Medical | 1 | 1998 | 261 | 0.030 |
Why?
|
| Communication Barriers | 1 | 1996 | 67 | 0.030 |
Why?
|
| Analgesics | 2 | 2006 | 102 | 0.030 |
Why?
|
| Common Bile Duct | 1 | 1995 | 19 | 0.030 |
Why?
|
| Reproductive Health | 1 | 2015 | 25 | 0.030 |
Why?
|
| Travel | 1 | 2015 | 42 | 0.030 |
Why?
|
| Energy Intake | 1 | 1996 | 171 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2015 | 69 | 0.030 |
Why?
|
| Dietary Fats | 1 | 1996 | 174 | 0.030 |
Why?
|
| Markov Chains | 1 | 2014 | 37 | 0.030 |
Why?
|
| New South Wales | 1 | 1994 | 3 | 0.030 |
Why?
|
| Insurance Claim Review | 1 | 2015 | 76 | 0.030 |
Why?
|
| Treatment Failure | 2 | 2007 | 201 | 0.030 |
Why?
|
| Personality Disorders | 1 | 1994 | 20 | 0.030 |
Why?
|
| Probability | 1 | 2014 | 170 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2014 | 122 | 0.030 |
Why?
|
| Schizophrenic Psychology | 1 | 1994 | 66 | 0.030 |
Why?
|
| Specialty Boards | 1 | 2014 | 15 | 0.030 |
Why?
|
| Crisis Intervention | 1 | 1994 | 27 | 0.030 |
Why?
|
| Bronchial Spasm | 1 | 1993 | 8 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2015 | 136 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 2167 | 0.030 |
Why?
|
| Angioedema | 1 | 1993 | 10 | 0.030 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 1993 | 13 | 0.030 |
Why?
|
| Time and Motion Studies | 1 | 2013 | 18 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 1994 | 372 | 0.030 |
Why?
|
| Electrocardiography | 1 | 1996 | 555 | 0.030 |
Why?
|
| Smoking | 3 | 1993 | 866 | 0.030 |
Why?
|
| Anaphylaxis | 1 | 1993 | 40 | 0.030 |
Why?
|
| Immunoglobulin E | 1 | 1993 | 80 | 0.030 |
Why?
|
| Emergencies | 1 | 1993 | 120 | 0.030 |
Why?
|
| Ownership | 1 | 2012 | 19 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2015 | 1356 | 0.020 |
Why?
|
| Hospitals, Psychiatric | 2 | 2004 | 56 | 0.020 |
Why?
|
| Calmodulin | 1 | 1992 | 22 | 0.020 |
Why?
|
| Self-Help Groups | 1 | 1992 | 37 | 0.020 |
Why?
|
| Health Maintenance Organizations | 1 | 1992 | 60 | 0.020 |
Why?
|
| Schizophrenia | 1 | 1994 | 265 | 0.020 |
Why?
|
| Administrative Personnel | 1 | 1992 | 31 | 0.020 |
Why?
|
| Actin Cytoskeleton | 1 | 1992 | 76 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1992 | 102 | 0.020 |
Why?
|
| Proteins | 2 | 2000 | 750 | 0.020 |
Why?
|
| Automation | 1 | 2011 | 54 | 0.020 |
Why?
|
| Kidney | 1 | 2014 | 447 | 0.020 |
Why?
|
| Living Donors | 2 | 2002 | 77 | 0.020 |
Why?
|
| Tobacco Smoke Pollution | 1 | 1991 | 57 | 0.020 |
Why?
|
| Tissue Donors | 2 | 2002 | 152 | 0.020 |
Why?
|
| Awareness | 1 | 1991 | 74 | 0.020 |
Why?
|
| Alcoholism | 1 | 1994 | 318 | 0.020 |
Why?
|
| Ear Ossicles | 2 | 2001 | 5 | 0.020 |
Why?
|
| Attitude | 1 | 1991 | 99 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 66 | 0.020 |
Why?
|
| Muscles | 1 | 1992 | 179 | 0.020 |
Why?
|
| Creatine | 1 | 2011 | 24 | 0.020 |
Why?
|
| Educational Status | 1 | 1992 | 275 | 0.020 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 350 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2011 | 28 | 0.020 |
Why?
|
| Actins | 1 | 1992 | 259 | 0.020 |
Why?
|
| Naval Medicine | 1 | 2010 | 1 | 0.020 |
Why?
|
| Health Education | 1 | 1992 | 189 | 0.020 |
Why?
|
| Cause of Death | 2 | 2002 | 221 | 0.020 |
Why?
|
| Recurrence | 1 | 1992 | 641 | 0.020 |
Why?
|
| Review Literature as Topic | 1 | 2010 | 37 | 0.020 |
Why?
|
| Occupational Health | 1 | 1992 | 187 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 1992 | 337 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1991 | 183 | 0.020 |
Why?
|
| Employment | 1 | 1991 | 127 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 2 | 2002 | 233 | 0.020 |
Why?
|
| Advisory Committees | 1 | 2010 | 112 | 0.020 |
Why?
|
| Occupational Diseases | 1 | 1991 | 268 | 0.020 |
Why?
|
| Inservice Training | 1 | 2009 | 86 | 0.020 |
Why?
|
| Israel | 1 | 1989 | 26 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 392 | 0.020 |
Why?
|
| Focus Groups | 1 | 2010 | 303 | 0.020 |
Why?
|
| Hypertension | 1 | 2014 | 585 | 0.020 |
Why?
|
| Calcium | 1 | 1992 | 573 | 0.020 |
Why?
|
| Military Personnel | 1 | 2010 | 119 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 1991 | 316 | 0.020 |
Why?
|
| Palliative Care | 2 | 2001 | 229 | 0.020 |
Why?
|
| Health Services Misuse | 1 | 2008 | 18 | 0.020 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2008 | 86 | 0.020 |
Why?
|
| Nursing Service, Hospital | 1 | 2007 | 2 | 0.020 |
Why?
|
| Prednisolone | 1 | 1987 | 8 | 0.020 |
Why?
|
| Ultrasonography | 2 | 2000 | 482 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2001 | 753 | 0.020 |
Why?
|
| Ethics, Research | 1 | 2007 | 20 | 0.020 |
Why?
|
| Amitriptyline | 1 | 2006 | 7 | 0.020 |
Why?
|
| Venlafaxine Hydrochloride | 1 | 2006 | 15 | 0.020 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2006 | 9 | 0.020 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2006 | 13 | 0.020 |
Why?
|
| Cyclohexanols | 1 | 2006 | 17 | 0.020 |
Why?
|
| Personnel Loyalty | 1 | 2006 | 1 | 0.020 |
Why?
|
| Health Facilities | 1 | 2006 | 43 | 0.020 |
Why?
|
| Amines | 1 | 2006 | 30 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 1992 | 893 | 0.020 |
Why?
|
| Serotonin | 1 | 2006 | 60 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2007 | 205 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2006 | 75 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2000 | 973 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2006 | 102 | 0.020 |
Why?
|
| Contract Services | 1 | 2005 | 2 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2007 | 217 | 0.010 |
Why?
|
| Northwestern United States | 1 | 2003 | 1 | 0.010 |
Why?
|
| Motivation | 1 | 2006 | 284 | 0.010 |
Why?
|
| Pessaries | 1 | 2003 | 4 | 0.010 |
Why?
|
| Administration, Intravaginal | 1 | 2003 | 12 | 0.010 |
Why?
|
| Sexuality | 1 | 2003 | 25 | 0.010 |
Why?
|
| Thyroxine-Binding Proteins | 1 | 2002 | 2 | 0.010 |
Why?
|
| Estrone | 1 | 2002 | 13 | 0.010 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2002 | 17 | 0.010 |
Why?
|
| Atrophy | 1 | 2003 | 83 | 0.010 |
Why?
|
| Placebos | 1 | 2002 | 72 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 2003 | 163 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2002 | 85 | 0.010 |
Why?
|
| Race Relations | 1 | 2002 | 3 | 0.010 |
Why?
|
| Transplantation Chimera | 1 | 2001 | 40 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 369 | 0.010 |
Why?
|
| Diagnostic Techniques, Otological | 1 | 2001 | 2 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2000 | 34 | 0.010 |
Why?
|
| Anthropology, Cultural | 1 | 2001 | 11 | 0.010 |
Why?
|
| Cholesteatoma | 1 | 2000 | 1 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 2000 | 22 | 0.010 |
Why?
|
| Endoscopes | 1 | 2000 | 7 | 0.010 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2000 | 13 | 0.010 |
Why?
|
| Transplantation Tolerance | 1 | 2000 | 65 | 0.010 |
Why?
|
| Cell Separation | 1 | 2000 | 147 | 0.010 |
Why?
|
| Rehabilitation | 1 | 2000 | 7 | 0.010 |
Why?
|
| Socialization | 1 | 2000 | 13 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2000 | 244 | 0.010 |
Why?
|
| Intermediate Filament Proteins | 1 | 2000 | 19 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2000 | 148 | 0.010 |
Why?
|
| Health Benefit Plans, Employee | 1 | 2000 | 13 | 0.010 |
Why?
|
| Keratins | 1 | 2000 | 31 | 0.010 |
Why?
|
| Rheumatoid Factor | 1 | 2000 | 13 | 0.010 |
Why?
|
| Peptides, Cyclic | 1 | 2000 | 22 | 0.010 |
Why?
|
| CA-19-9 Antigen | 1 | 2000 | 10 | 0.010 |
Why?
|
| Amylases | 1 | 2000 | 12 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 2000 | 32 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1980 | 30 | 0.010 |
Why?
|
| Coenzyme A Ligases | 1 | 2000 | 13 | 0.010 |
Why?
|
| Inactivation, Metabolic | 1 | 2000 | 14 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2001 | 517 | 0.010 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2000 | 32 | 0.010 |
Why?
|
| Seroepidemiologic Studies | 1 | 2000 | 52 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2000 | 102 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2000 | 488 | 0.010 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 1980 | 57 | 0.010 |
Why?
|
| Citrulline | 1 | 2000 | 44 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 92 | 0.010 |
Why?
|
| Transportation of Patients | 1 | 1980 | 47 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2000 | 107 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2000 | 138 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 463 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2000 | 192 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2000 | 278 | 0.010 |
Why?
|
| Endarterectomy, Carotid | 1 | 2000 | 91 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 2000 | 101 | 0.010 |
Why?
|
| Pancreas | 1 | 2000 | 150 | 0.010 |
Why?
|
| Risk-Taking | 1 | 2000 | 162 | 0.010 |
Why?
|
| Physicians | 1 | 2004 | 470 | 0.010 |
Why?
|
| Epitopes | 1 | 2000 | 289 | 0.010 |
Why?
|
| Amenorrhea | 1 | 1997 | 6 | 0.010 |
Why?
|
| Forearm | 1 | 1997 | 21 | 0.010 |
Why?
|
| Work | 1 | 1997 | 15 | 0.010 |
Why?
|
| Cumulative Trauma Disorders | 1 | 1997 | 17 | 0.010 |
Why?
|
| Osteolysis | 1 | 1997 | 18 | 0.010 |
Why?
|
| Aging | 1 | 2003 | 745 | 0.010 |
Why?
|
| Sports | 1 | 1997 | 96 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2000 | 506 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2000 | 2151 | 0.010 |
Why?
|
| Canada | 1 | 1996 | 154 | 0.010 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1996 | 97 | 0.010 |
Why?
|
| Language | 1 | 1996 | 150 | 0.010 |
Why?
|
| Myristoylated Alanine-Rich C Kinase Substrate | 1 | 1992 | 2 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1997 | 739 | 0.010 |
Why?
|
| ROC Curve | 1 | 1993 | 279 | 0.010 |
Why?
|
| Employee Grievances | 1 | 1991 | 1 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 250 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1992 | 116 | 0.010 |
Why?
|
| Occupational Health Services | 1 | 1991 | 37 | 0.010 |
Why?
|
| Rabbits | 1 | 1992 | 332 | 0.010 |
Why?
|
| Cattle | 1 | 1992 | 308 | 0.010 |
Why?
|
| Kinetics | 1 | 1992 | 760 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1992 | 935 | 0.000 |
Why?
|
| Homeostasis | 1 | 1992 | 369 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 1592 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1992 | 1990 | 0.000 |
Why?
|
| Intestinal Absorption | 1 | 1987 | 30 | 0.000 |
Why?
|
| Animals | 1 | 1992 | 20613 | 0.000 |
Why?
|